Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

Withdrawn before enrolling

Conditions studied: Blood Clots, Vascular Disease, Embolism Thrombosis, Cardiovascular Diseases, Lung Diseases

In brief

Assess the functionality of the Versus Catheter for catheter-directed thrombolysis of pulmonary blood clots, including advanced imaging assessment. An evaluation of patient outcomes from the cases included in this study will also be conducted.

Key facts

Study ID

NCT06975969

Run by

Liquet Medical Inc.

People needed

0

Starts

2025-09-05

Expected to finish

2026-02-20

Last updated by the study team

2026-03-05

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 - 80 years, inclusive
• Patients who present with submassive pulmonary embolism (PE)
• Patients requiring thrombolytic intervention to the pulmonary vasculature
• Physician decision to use the Versus™ Catheter during the treatment of the patient

You may not qualify if…

• Concurrent treatment with thrombectomy
• Concurrent treatment with a catheter-directed thrombolysis device that is NOT the Versus™ Catheter
• Massive pulmonary embolism (PE)
• Active bleeding disorder1
• Recent cerebrovascular accident or transient ischemic attack1
• Recent neurosurgery1
• Recent intracranial trauma1
• Absolute contraindication to anticoagulation1
• BMI > 45kg/m2
• In the opinion of the investigator, the participant is not a suitable candidate for the study

Where it is running

• University of Virginia Medical Center — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.